BRCA2 and cancer: Studies have suggested much smaller increases in cancer risk and smaller contributions to cancer incidence for stomach, pancreas, uterine, cervix, and colon cancer for BRCA1, and prostate, pancreatic, gallbladder, stomach cancer, and melanoma for BRCA2 (5–7).